News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Myeloma Paper of the Day, April 8th, suggested by Robert Orlowski
Apr 8, 2025, 10:39

Myeloma Paper of the Day, April 8th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: S-MRD<10-5 (sustained MRD two consecutive tests at least 1 year apart) is best PFS predictor and yields best predictive models for risk of MRD resurgence or progression after quad induction + ASCT and fixed duration therapy.”

“Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma”

Authors: Smith Giri, Binod Dhakal, Natalie Callander, Eva Medvedova, Kelly Godby, Bhagirathbhai Dholaria, Susan Bal, Gayathri Ravi, Saurabh Chhabra, Rebecca Silbermann, Luciano Costa.

Myeloma Paper of the Day, April 8th, suggested by Robert Orlowski

More posts featuring Robert Orlowski.

Bhagirathbhai Dholaria Binod Dhakal cancer Eva Medvedova Gayathri Ravi Kelly Godby Luciano Costa multiple myeloma Myeloma Paper of the Day Natalie Callander OncoDaily Oncology Rebecca Silbermann Robert Orlowski Saurabh Chhabra Smith Giri Susan Bal
Special Coverage
Blog
May 5, 2025, 08:18
Rob Winn Reflects on VCU Massey’s Presence at AACR 2025 Annual Meeting
Blog
May 5, 2025, 08:03
Elisa Pucu: What are the main barriers for cancer control in the Amazon?
Insight
May 5, 2025, 07:50
Rami Manochakian: Burnout and Resilience - Connection on a Very Important Topic for Oncologists and Trainees
Science
May 5, 2025, 07:08
Top clinical trials at ESTRO 2025: Nivolumab plus ChemoRT in Patients with Muscle-Invasive Bladder Cancel. Final Results of a Phase Il Study by the HGUCG
Blog
May 5, 2025, 06:55
Sachin H. Jain: I am now seeking a terrific new partner to serve as my executive assistant at SCAN
Science
May 5, 2025, 06:45
FLAME Trial at ESTRO 2025. Focal Boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 10-year Results
Blog
May 5, 2025, 06:41
Peter Pisters: We Celebrate Employee Appreciation Month at MD Anderson Cancer Center
Science
May 5, 2025, 06:35
PORTEC-4a at ESTRO 2025: International randomised trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer
Blog
May 5, 2025, 06:27
The American Cancer Society is proud to announce Terri McClements’ appointment as Chair of its National Board of Directors
Blog
May 5, 2025, 06:06
Amol Akhade Shares Survey on Impact of Social Media on Oncology Practice
Blog
May 5, 2025, 06:01
Stavroula Chante: Join us this European Cancer Nursing Day to honor, appreciate, and elevate cancer nursing
Blog
May 5, 2025, 05:17
Join Virtual Round Table Discussion on Navigating Treatment Strategies in the Management of Early and Locally Advanced NSCLC